인간 메타뉴모바이러스 바이러스 벡터-기반 백신

본 개시내용은 hMPV F 단백질 항원을 포함하는 인간 메타뉴모바이러스(hMPV) 백신, 및 상기 백신을 투여함으로써 면역 반응을 유발하는 방법을 제공한다. The present disclosure provides a human metapneumovirus (hMPV) vaccine comprising an hMPV F protein antigen, and methods of eliciting an immune response by administering said vaccine....

Full description

Saved in:
Bibliographic Details
Main Authors DINAPOLI JOSH, DANZ HILLARY, CHIVUKULA SUDHA, DAHAL BIBHA, MUNDLE SOPHIA, BUCHHOLZ URSULA, KISHKO MICHAEL, ZHANG LINONG, ANOSOVA NATALIE, SASMAL SUKANYA, GROPPO RACHEL, STRUGNELL TOD, COLLINS PETER, CHAN YVONNE, ALAMARES SAPUAY JUDITH, MUNIR SHIRIN, STUEBLER ANTONIA
Format Patent
LanguageKorean
Published 05.08.2024
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:본 개시내용은 hMPV F 단백질 항원을 포함하는 인간 메타뉴모바이러스(hMPV) 백신, 및 상기 백신을 투여함으로써 면역 반응을 유발하는 방법을 제공한다. The present disclosure provides a human metapneumovirus (hMPV) vaccine comprising an hMPV F protein antigen, and methods of eliciting an immune response by administering said vaccine.
Bibliography:Application Number: KR20247021286